TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EXOZ

eXoZymes, Inc.

Healthcare · Biotechnology

6.40$ +4.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EXOZ
Line item 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
44.6% 54.7% 34.1% 83.0% 66.0%
23.3% 20.8% 1.9% 74.6% 50.9%
23.3% 20.8% 1.9% 74.6% 50.9%
20.0% 30.1% 24.8% 5.7% 8.7%
49.0% 48.9% 110.8% 20.1% 43.1%
17.1% 23.6% 67.9% 10.2% 26.2%
5.7% 5.4% 6.3% 1.8% 5.5%
11.4% 14.4% 19.8% 7.1% 20.7%
51.0% 51.1% -10.8% 79.9% 56.9%
-113.0% -150.7% -171.0% -91.6% -353.4%
346.4% 302.6% 228.4% 62.4% 140.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?